ReviewFrontiers in immunology2024

Corneal application of SOCS1/3 peptides for the treatment of eye diseases mediated by inflammation and oxidative stress.

Chulbul M Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.